Incidence of haploidy and triploidy in trophectoderm biopsies of blastocysts derived from normally and abnormally fertilized oocytes.

Autor: Girardi L; Igenomix Italy, Reproductive Genetics, Marostica, Italy. laura.girardi@igenomix.com., Patassini C; Igenomix Italy, Reproductive Genetics, Marostica, Italy., Miravet Valenciano J; Igenomix Spain Lab S.L.U., Research and Development, Paterna, Spain., Sato Y; Igenomix Japan, Laboratory of Reproductive Genetics, Tokyo, Japan., Fagundes Cagnin N; Igenomix Brazil, Laboratory of Genetic Medicine, São Paulo, Brazil., Castellón JA; Igenomix R&D, Medical Department, Paterna, Spain., Cogo F; Igenomix Italy, Reproductive Genetics, Marostica, Italy., Zambon P; Igenomix Italy, Reproductive Genetics, Marostica, Italy., Blesa D; Igenomix Spain Lab S.L.U., Research and Development, Paterna, Spain., Jimenez Almazan J; Igenomix Spain Lab S.L.U., Research and Development, Paterna, Spain., Akinwole A; Igenomix USA, Laboratory of Genetic Medicine, Miami, FL, USA., Coprerski B; Igenomix Brazil, Laboratory of Genetic Medicine, São Paulo, Brazil., Rubio C; Igenomix Spain Lab S.L.U., Research and Development, Paterna, Spain.

Publikováno v: Journal of assisted reproduction and genetics [J Assist Reprod Genet] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.

Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells.

Autor: Colucci M; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Faculty of Biology and Medicine, University of Lausanne UNIL, CH1011 Lausanne, Switzerland., Zumerle S; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy., Bressan S; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Gianfanti F; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Troiani M; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Bioinformatics Core Unit, Swiss Institute of Bioinformatics, TI, Bellinzona, Switzerland., Valdata A; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, CH, Switzerland., D'Ambrosio M; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; MRC London Institute of Medical Sciences (LMS), London, UK., Pasquini E; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Varesi A; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Cogo F; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Mosole S; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Dongilli C; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Desbats MA; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy., Contu L; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy., Revankdar A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA., Chen J; Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Kalathur M; Children's GMP, LLC, St. Jude Children's Research Hospital, 262 Danny Thomas Place Mail Stop 920 Memphis, TN 38105, USA., Perciato ML; School of Clinical Dentistry, University of Sheffield, Sheffield S10 2TA, UK., Basilotta R; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 viale Ferdinando D'Alcontres, Italy., Endre L; Functional Genomics Center Zurich, ETHZ and University of Zurich, Zurich, CH, Switzerland., Schauer S; Functional Genomics Center Zurich, ETHZ and University of Zurich, Zurich, CH, Switzerland., Othman A; Functional Genomics Center Zurich, ETHZ and University of Zurich, Zurich, CH, Switzerland., Guccini I; Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, CH, Switzerland., Saponaro M; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy., Maraccani L; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Bancaro N; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Lai P; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Liu L; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Pernigoni N; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Mele F; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland., Merler S; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine, University of Verona and Verona University and Hospital Trust, Verona, Italy., Trotman LC; Cold Spring Harbor Laboratory, One Bungtown Road, Cold Spring Harbor, NY 11724, USA., Guarda G; Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland., Calì B; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland., Montopoli M; Veneto Institute of Molecular Medicine (VIMM) & Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy., Alimonti A; Institute of Oncology Research (IOR), CH6500 Bellinzona, Switzerland; Università della Svizzera Italiana, CH6900 Lugano, Switzerland; Veneto Institute of Molecular Medicine (VIMM) & Department of Medicine, University of Padova, Padova, Italy; Department of Health Sciences and Technology (D-HEST) ETH Zurich, Zurich, CH, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. Electronic address: andrea.alimonti@ior.usi.ch.

Publikováno v: Cancer cell [Cancer Cell] 2024 Apr 08; Vol. 42 (4), pp. 646-661.e9. Date of Electronic Publication: 2024 Feb 29.

The use of copy number loads to designate mosaicism in blastocyst stage PGT-A cycles: fewer is better.

Autor: Girardi L; Igenomix, Reproductive Genetics, Marostica, Italy., Figliuzzi M; Igenomix, Reproductive Genetics, Marostica, Italy., Poli M; Igenomix, Reproductive Genetics, Marostica, Italy., Serdarogullari M; Faculty of Medicine, Cyprus International University, Northern Cyprus, Turkey., Patassini C; Igenomix, Reproductive Genetics, Marostica, Italy., Caroselli S; Igenomix, Reproductive Genetics, Marostica, Italy., Pergher I; Igenomix, Reproductive Genetics, Marostica, Italy., Cogo F; Igenomix, Reproductive Genetics, Marostica, Italy., Coban O; British Cyprus IVF Hospital, Nicosia, Cyprus., Boynukalin FK; Bahceci Fulya IVF Centre, Infertility Clinic, Istanbul, Turkey., Bahceci M; Bahceci Fulya IVF Centre, Infertility Clinic, Istanbul, Turkey., Navarro R; Igenomix Spain, Valencia, Spain., Rubio C; Igenomix Spain, Valencia, Spain., Findikli N; Bahceci Fulya IVF Centre, Embryology Laboratory, Istanbul, Turkey., Simón C; Department of Obstetrics and Gynecology, Valencia University; and INCLIVA, Valencia, Spain.; Department of Obstetrics and Gynecology, Harvard School of Medicine, Harvard University, Cambridge, MA, USA.; Carlos Simón Foundation, Valencia, Spain., Capalbo A; Igenomix, Reproductive Genetics, Marostica, Italy.

Publikováno v: Human reproduction (Oxford, England) [Hum Reprod] 2023 May 02; Vol. 38 (5), pp. 982-991.

Molecular tools for the genomic assessment of oocyte's reproductive competence.

Autor: Picchetta L; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Caroselli S; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Figliuzzi M; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Cogo F; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Zambon P; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Costa M; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Pergher I; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Patassini C; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Cortellessa F; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Zuccarello D; Department of Lab Medicine, Unit of Clinical Genetics and Epidemiology, University Hospital of Padova, 35128, Padova, Italy., Poli M; Igenomix, Reproductive Genetics, 36063, Marostica, Italy., Capalbo A; Igenomix, Reproductive Genetics, 36063, Marostica, Italy. antonio.capalbo@igenomix.com.

Publikováno v: Journal of assisted reproduction and genetics [J Assist Reprod Genet] 2022 Apr; Vol. 39 (4), pp. 847-860. Date of Electronic Publication: 2022 Feb 05.

Technical factors to consider when developing an Expanded Carrier Screening platform.

Autor: Fabiani M; Igenomix Italia, Marostica, Vicenza, Italy., Cogo F; Igenomix Italia, Marostica, Vicenza, Italy., Poli M; Igenomix Italia, Marostica, Vicenza, Italy., Capalbo A; Igenomix Italia, Marostica, Vicenza, Italy.; Igenomix Foundation, Valencia, Spain.

Publikováno v: Current opinion in obstetrics & gynecology [Curr Opin Obstet Gynecol] 2021 Jun 01; Vol. 33 (3), pp. 178-183.